See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2022_Agile_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001261249, Agile Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 23,925,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,447,000 |
| 3 | remainder_Assets | 2,961,000 |
| 4 | LiabilitiesCurrent | 29,278,000 |
| 5 | LiabilitiesNoncurrent | 784,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 62,898,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,158,278 |
| 9 | ResearchAndDevelopmentExpense | 2,713,674 |
| 10 | remainder_Expenses | 101,156,900 |
| 11 | remainder_Revenues | 20,860,999 |
| 12 | remainder_NetIncome | -3,707,021 |
| 13 | remainder_ComprehensiveNetIncome | 2,999 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 39,333,000 |
| 1 | Liabilities | 30,062,000 |
| 2 | Expenses | 181,926,852 |
| 3 | Revenues | 20,860,999 |
| 4 | StockholdersEquity | 9,271,000 |
| 5 | NetIncome | -164,772,874 |
| 6 | ComprehensiveNetIncome | -164,771,374 |
| 7 | BaseVar | 137,946,436 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.17 |
| 9 | EconomicCapitalRatio | 0.352 |
Edgar->Model Mapping
Feature Distribution
Change over Time
